Heart disease is the leading cause of death in Americans, claiming hundreds of thousands of lives yearly. The ability to diagnose and treat patients sooner and with more accuracy is key to winning the war against heart disease.
June 12, 2008 - There is a lack of universally applied standards for administering radiopharmaceutical doses to children ...
June 11, 2008 - TraumaCure Inc. said last week the DOD Joint Committee on Tactical Combat Casualty Care (CoTCCC) ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
OrbusNeich's Scoreflex coronary dilatation catheter, which is only CE Mark approval, but not yet FDA cleared, is a new ...
June 10, 2008 – A new calcium scoring method, which takes into account not only the amount of calcified plaque build-up ...
June 10, 2008 - The use of ultrasound contrast agents during stress echocardiograms is safe, according to results ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Researchers are using speckle tracking imaging in heart ultrasound to monitor the health of transplant acceptance, and ...
June 10, 2008 - OrbusNeich received CE Mark approval for the Scoreflex coronary dilatation catheter, a new product that ...
June 8, 2008 - Inhalation of carbon monoxide (CO) can reduce skeletal muscle injury after the following limb peripheral ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 9, 2008 - Siemens unveiled the ACUSON SC2000 volume imaging ultrasound system, which acquires nonstitched, real ...
June 8, 2008 - A new study about how shear stress improves adult stem cell attachment to vascular surfaces moves researchers closer to the development of a unique tissue-engineered stem cell vascular bypass graft, reported a study presented during the Vascular Annual Meeting, June 5-8, in San Diego, CA.
June 9, 2008 - Siemens Medical Solutions gained FDA 510(k) market clearance for the SOMATOM Definition AS, what is said ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Acusphere has submitted a New Drug Application (NDA) to the FDA for approval to market Imagify (Perflubutane Polymer Microspheres for Injectable Suspension), an ultrasound imaging agent for the detection of coronary artery disease, which could prove as accurate as nuclear stress testing.
June 9, 2008 - Atrium Medical has begun enrollment of the first patients for their CONFIRM 1, First-in-Man (FIM) drug ...
June 5, 2008 - Older patients may have less ability to repair of vessels and arteries after acute injury, similar to other effects of aging, according to the American Vascular Association (AVA) Resident Research Prize Paper, presented at the 62nd Annual Meeting of the Society for Vascular Surgery.
June 11, 2008
